BNET Industries

Beijing Med-Pharm Corp.

(BJGP) is in the Pharma Industry

Market Cap:$174.9M
Last Fiscal Year Sales:$114.8M
  • Public
  • US
Dow Jones Description

Beijing Med-Pharm is a Delaware Corporation with Chinese subsidiaries. We are able to offer an end-to-end solution to western pharmaceutical companies interested in selling their products into the Chinese marketplace. Services we offer include: - Pre-market entry analysis - Clinical trial management - Pre-registration and registration of pharmaceuticals for sale in the People's Republic of China - Market research - Pharmaceutical marketing to physicians, hospitals, and other healthcare providers - Pharmaceutical distribution to hospitals In December 2004, Beijing Med-Pharm signed an agreement to purchase Beijing Wanwei Pharmaceutical Corporation, Ltd., a pharmaceutical distributor covering the bulk of Beijing's hospitals. This was a historic event, the first-ever purchase of a Chinese pharmaceutical distribution company by a foreign entity, permitted only after a December 2004 change in Chinese law. By adding this distributor to our already-existing sales and marketing services, Beijing Med-Pharm hopes to offer an unparalleled opportunity to reach China, the world's fastest-growing market. And our veteran pharmaceutical management staff makes it simple for you to do so. Beijing Med-Pharm serves as your entry point for pharmaceutical distribution into China. Contact us bd@beijingmedpharm.com for more information on how we can best serve you. Beijing Med-Pharm CEO David Gao (left) signs an agreement with the Beijing Wan Hui Pharmaceutical Group, represented by Chairman Wang...

President & COO
Zhiqiang Han
Number of Employees 1,273
Contact Information

600 W Germantown Pike Ste 400

Plymouth Meeting, Pennsylvania 19462

www.beijingmedp...

(610) 940-1675

NAICS Code Drugs and Druggists' Sundries Merchant Wholesalers: 424210

Recent Events

  • Pfizer says in partnership deal with BMP in China

    11/10/09 - Joint Venture / Alliance - View Story

  • Pfizer Inc. PFE Says in Partnership Deal with BMP Sunstone in China

    11/10/09 - Joint Venture / Alliance - View Story

  • BMP Sunstone BJGP Reports In-line Results for Q3; Guides Below for FY Revenues

    11/10/09 - Financial Announcement - View Story

  • BMP Sunstone Appoints Daniel Harrington to Board of Directors

    10/29/09 - Board Member - Entering - View Story

  • BMP Sunstone Reports Second Quarter 2009 Financial Results

    8/10/09 - Financial Announcement - View Story

News & Analysis

beijing med-pharm corp. - All News and Analysis

Decision Makers

Name (plus bio) Position
Zhiqiang Han President & COO
Fred M Powell Chief Financial Officer
Byron Wang Vice President, Sales & Marketing
Yanping Zhao Vice President
Yong Guo General Manager, Beijing Wanwei Pharmaceutical
Amy Zhou Director, Human Resources, China
Bin Duan Marketing Manager
Frank Xu National Sales Manager
Richard Liu Manager, Business Development
Han Zhiqiang
Albert Yeung Director
Frank J. Hollendoner Director
George Bickerstaff Director
John W. Stakes Director

Board of Directors

Name (plus bio) Position
Zhijun Tong Director, Chairman of Qifa
Martyn D. Greenacre Chairman of the Board
David Gao Board of Directors
Jack M. Ferraro Board of Directors
Les R. Baledge Board of Directors

Organization Position Status
BMP Sunstone Corporation President & COO Current
Sunstone, Inc. Founder Current
BMP Sunstone Corporation Board of Directors Current

Mr. Powell has served as BMP Sunstone’s Chief Financial Officer since January 2005. And prior to this, he had been with Eximias Pharmaceutical Corporation as the CFO since May 2002. He was Senior Vice President, Finance and Administration, at InnaPhase where he was mainly responsible for all financial, internal control, HR, administrative, and legal affairs. At Premier Research Worldwide (PRWW), Mr. Powell served as CFO and helped PRWW become one of the nation’s leading clinical research organizations by leading the Company’s initial public offering and managing several acquisitions, including DLB, a clinical trial and data management software company. From 1983 to 1989, Mr. Powell spent seven years at KPMG Peat Marwick as a Senior Manager responsible for directing the planning, coordination and deliver of audit management and technology services to clients in the pharmaceutical and services industries. Mr. Powell graduated from Penn State University in 1983, with a Bachelor of Sciences in Accounting and is a Certified Public Accountant.

Organization Position Status
BMP Sunstone Corporation Chief Financial Officer Current
Eximias Pharmaceutical Corporation Chief Financial Officer Former
InnaPhase Corporation Senior Vice President, Finance and Administration Former
The Pennsylvania State University Bachelor of Science In Accounting Former

Organization Position Status
BMP Sunstone Corporation Vice President, Sales & Marketing Current

Ms. Zhao has served as BMP Sunstone’s Corporate Vice President since October 2007. From 1992 until 2007, Ms. Zhao held various senior positions with Sino Biopharmaceutical Ltd, where she held senior posts of Vice President and Executive Director in the Corporation, Executive Director in Shandong Chia Tai Freda Pharmaceutical Ltd, as well as Managing Director of its subsidiaries. Ms. Zhao also served as Department Head at Inner Mongolia Medicine and Health Products Import Export Corporation, and Deputy Plan Manager at Inner Mongolia Yuanbaoshan Pharmaceutical Ltd during 1983 to 1992. Ms. Zhao has a Pharmaceutical degree from Shenyang Pharmaceutical University and a MBA from Dalian University of Technology.

Organization Position Status
BMP Sunstone Corporation Vice President Current

Organization Position Status
BMP Sunstone Corporation General Manager, Beijing Wanwei Pharmaceutical Current

Organization Position Status
BMP Sunstone Corporation Director, Human Resources, China Current

Organization Position Status
BMP Sunstone Corporation Director, Chairman of Qifa Current
BMP Sunstone Corporation Board of Directors Former
Sunstone, Inc. Vice Chairman Former

Organization Position Status
BMP Sunstone Corporation Marketing Manager Current

Organization Position Status
BMP Sunstone Corporation National Sales Manager Current

Organization Position Status
BMP Sunstone Corporation Manager, Business Development Current

Organization Position Status
BMP Sunstone Corporation Current
Sunstone, Inc. Founder Former

Since July 2004, Mr. Greenacre has served as Chairman of Beijing Med-Pharm Corporation, a pharmaceutical company. Mr. Greenacre also has served since 2002 as Chairman of Life Mist Technologies, Inc., a fire suppression equipment company. From 1997 to 2001, Mr. Greenacre served as Chief Executive Officer and director of Delsys Pharmaceutical Corporation, a formulation and drug delivery system company. From 1993 to 1997, Mr.

Organization Position Status
Life Mist Technologies, Inc. Chairman Current
Curis, Inc. Chair Current
BMP Sunstone Corporation Chairman of the Board Current
Lifemist Chairman Current
Pathway 2 Curis Board of Directors Current
Personalized Medicine Coalition Board of Directors Current
Cephalon, Inc. Board of Directors Current
Acusphere, Inc. Director Current
BMP Sunstone Corporation Committee Member Current
GlaxoSmithKline Plc Chairman Former
Creative BioMolecules, Inc. Director Former
BMP Sunstone Corporation Board of Directors Former
Curis, Inc. Director Former
Orchestra Therapeutics, Inc. Director Former

Organization Position Status
BMP Sunstone Corporation Director Current

Organization Position Status
BMP Sunstone Corporation Board of Directors Current
Abacus Corporation Chief Executive Officer Former
BMP Sunstone Corporation Chairman, President & CEO Former
Abacus Corporation President Former
Abacus Corporation Director Former
Massachusetts, Inc. M.B.A. Former
Beijing Institute of Technology Bsc In Mechanical Engineering Former

Organization Position Status
Doughty Hanson & Co. Ltd. Board of Directors Current
BMP Sunstone Corporation Director Current
Doughty Hanson & Co. Ltd. Chairman of the Board of Directors Former
Independent Care Group Limited Executive Chairman of the Board of Directors Former

Organization Position Status
USA India Chamber of Commerce Managing Director, Crt Investment Banking Current
CRT Capital Group LLC Managing Director Current
Sheffield Mechant Banking Group Current
Vion Pharmaceuticals, Inc. Board of Directors Current
Oracle Healthcare Acquisition Corp. Director Current
BMP Sunstone Corporation Director Current
Gavi Alliance Board of Directors Current
IMS Health, Inc. Cfo Former
Rutgers University B.S. Degree In Engineering Former
Rutgers University engineering and business degree Former

Organization Position Status
National Ability Center Board of Directors Current
The Advisory Council Board of Directors Current
BMP Sunstone Corporation Board of Directors Current
Hackley School Board of Directors Current
Neuberger Berman, Inc. Partner Former
Neuberger Berman, Inc. Manager Former

John W. Stakes III, M.D., has served as one of our directors since February 2004. Dr. Stakes has served as an Associate Neurologist at Massachusetts General Hospital since 1990, as Director, Massachusetts General Hospital Sleep Disorders Laboratory, since 1982, and as Director, Specialty Care Development, Massachusetts General Physicians Organization, since 1995. He was a member of the Committee on Continuing Medical Education of the Harvard Medical School. Dr. Stakes has held a teaching position at the Harvard Medical School since 1975.

Organization Position Status
Massachusetts General Hospital Associate Neurologist Current
BMP Sunstone Corporation Director Current

Organization Position Status
BMP Sunstone Corporation Board of Directors Current
Tyson Foods, Inc. General Counsel Former

Executive News

  • BMP Sunstone Announces September Investor Conference Participation

    Pharma Live - 9/04/09 - View Story

  • BMP Sunstone Reports Second Quarter 2009 Financial Results

    NewsBlaze - 8/10/09 - View Story

  • BMP Sunstone Reports Second Quarter 2009 Financial Results

    Yahoo! Canada - 8/10/09 - View Story

advertisement
     BJGP $4.21 -0.05 (-1.17% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 68,137
Shares Outstanding 41.56M
Market Cap 175.0M
Year High 6
Year Low 2.25
Earnings Per Share -0.07
P/E Ratio -60.14
Dividend N/A
Yield N/A
IndustryTop Rated
advertisement